For Healthcare Professionals

For Healthcare Professionals: Clinical Updates in Blood & Marrow Stem Cell Transplantation

Our program in bone and marrow stem cell transplantation is one of the largest and most established nationwide. Since performing the first successful stem cell transplant between a patient and an unrelated donor in the early 1970s, we have remained pioneering and productive in the field, carrying out more than 4,000 autologous and allogeneic transplants and introducing approaches now commonly used around the globe. Advances we have helped to develop include T cell depletion, hyperfractionated irradiation, and methods to prevent graft-versus-host disease.

Making an Appointment

Call 877-836-ABMT (2268) Mon–Fri, 8:30 AM–5:30 PM, ET

Learn more | Refer a patient

 

Treating CMV Reactivation Following Allogeneic Bone Marrow Transplant

Physician-scientist Guenther Koehne describes a T cell immunotherapy for resistant cytomegalovirus infection in allogeneic stem cell transplant patients.

Runtime: 04:00 minutes Published: 04/03/2013 - 9:07 AM
IL-7 Promotes T Cell Recovery after Allogeneic Stem Cell Transplantation

Medical oncologists Marcel van den Brink and Miguel-Angel Perales describe results of a phase I trial of IL-7 in stem cell transplantation.

Runtime: 03:00 minutes Published: 02/19/2013 - 1:19 PM
Regulation of Intestinal Inflammation by Microbiota following Allogeneic Bone Marrow Transplantation

Medical oncologist Robert Jenq describes the role of microbiota in regulating intestinal inflammation post-allogeneic bone marrow transplant.

Runtime: 03:00 minutes Published: 02/19/2013 - 9:36 AM
Extrathymic Development of Murine T Cells Post–Bone Marrow Transplant

Medical oncologist Marcel van den Brink explains that functioning T cells may be generated in abdominal lymph nodes following allogeneic bone marrow transplant.

Runtime: 03:00 minutes Published: 02/19/2013 - 9:28 AM
Predictor of Transplantation Failure in Relapsed and Refractory Follicular Lymphoma (2012 ASH Conference)

Fellow Matthew Lunning describes a retrospective study that examined event-free and overall survival among patients with relapsed/refractory follicular lymphoma.

Runtime: 03:00 minutes Published: 12/10/2012 - 1:11 PM
Donor-Recipient Matching of Unrelated Cord Blood Units (2012 ASH Conference)

Fellow Parastoo Dahi describes study results indicating that higher resolution HLA matching is possible without significantly compromising graft dose in unrelated cord blood transplantation.

Runtime: 03:00 minutes Published: 12/10/2012 - 9:16 AM
Graft-Specific HLA Antibodies in Double-Unit Cord Blood Transplantation (2012 ASH Conference)

Fellow Parastoo Dahi reviews a study that found that that graft-specific HLA antibodies do not influence unit dominance or prevent high rates of sustained donor engraftment in double-unit cord blood transplantation.

Runtime: 02:00 minutes Published: 12/10/2012 - 9:15 AM
Cord Blood Transplantation for Hematologic Malignancies: Improving Access and Outcomes

Cord blood extends access to transplants for the majority of patients.

Runtime: 04:00 minutes Published: 01/10/2012 - 1:51 PM
Bexxar/BEAM Versus Rituximab/BEAM and Autologous Stem Cell Transplantation (2011 ASH Conference)

Clinical Director of the Division of Hematologic Oncology Craig Moskowitz discusses a study comparing conditioning regimens followed by autologous stem cell transplantation.

Runtime: 02:00 minutes Published: 12/10/2011 - 10:31 AM